GC3114

· Green Cross Corporation

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for GC3114, covering 2019-01-04 to 2019-01-04. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Evaluate the Safety and Efficacy(Immunogenicity) of GC3114 in Elderly Healthy Subjects [Phase 2]